Mesenchymal Stem Cells in Central Nervous System injury2017

NCT03291366 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Injury

Interventions

DRUG: UCMSCC
DRUG: conventional treatment

Sponsor

Fuzhou General Hospital